FTC Tells Medtronic To Sell Intersect ENT Subsidiary To Avoid Monopoly
Executive Summary
The move removes all regulatory roadblocks to Medtronic’s $1.1bn acquisition of Intersect ENT, which was announced in August 2021.
You may also be interested in...
Medtronic Bolsters Sinus Portfolio With $1.1Bn Intersect ENT Buyout
Medtronic announced plans to acquire Intersect ENT, adding its sinus implants to Medtronic's portfolio of devices used by surgeons in treating chronic rhinosinusitis.
Company Faces False Claims Charges For Disposable Rectal Probe Reuse
The Prometheus Group reportedly told health care providers that they could reuse probes that were part of its pelvic floor therapy system on multiple patients by covering them with a condom or the finger of a rubber glove.
Federal Small Business Research Grant Programs At Risk Of Expiration, AdvaMed Says
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs will shut down on 30 September if Congress doesn’t act to renew them – but some US senators say the programs are wasteful and may funnel research overseas.